Total Payments
$3,473
2024 Payments
$940.66
Companies
25
Transactions
189
Medicare Patients
2,547
Medicare Billing
$453,915
Payment Breakdown by Category
Food & Beverage$3,465 (99.8%)
Education$7.29 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,465 | 188 | 99.8% |
| Education | $7.29 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,312 | 85 | $0 (2024) |
| Janssen Biotech, Inc. | $308.68 | 16 | $0 (2024) |
| Celgene Corporation | $292.10 | 14 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $212.45 | 13 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $178.13 | 12 | $0 (2024) |
| Gilead Sciences, Inc. | $136.13 | 12 | $0 (2021) |
| Covidien LP | $127.63 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $116.94 | 1 | $0 (2023) |
| PFIZER INC. | $105.20 | 6 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $99.87 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $940.66 | 50 | ABBVIE INC. ($495.71) |
| 2023 | $739.34 | 32 | ABBVIE INC. ($183.37) |
| 2022 | $258.40 | 14 | ABBVIE INC. ($70.32) |
| 2021 | $305.41 | 19 | AbbVie Inc. ($199.41) |
| 2020 | $141.96 | 9 | AbbVie Inc. ($108.75) |
| 2019 | $443.65 | 28 | AbbVie, Inc. ($112.37) |
| 2018 | $468.43 | 25 | Covidien LP ($127.63) |
| 2017 | $174.74 | 12 | AbbVie, Inc. ($73.08) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/11/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Rare Disease | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: VIROLOGY | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Neuroscience | ||||||
| 09/10/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Rare Disease | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $28.24 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 742 | 5,032 | $611,996 | $151,750 |
| 2022 | 13 | 683 | 6,770 | $689,356 | $174,459 |
| 2021 | 9 | 522 | 622 | $264,743 | $59,416 |
| 2020 | 12 | 600 | 734 | $323,567 | $68,289 |
Total Patients
2,547
Total Services
13,158
Medicare Billing
$453,915
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 11 | 4,200 | $241,500 | $72,541 | 30.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 140 | 142 | $145,550 | $28,561 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 171 | $46,170 | $15,268 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 112 | $20,720 | $7,055 | 34.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 89 | 91 | $58,695 | $7,015 | 12.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 95 | $11,400 | $5,816 | 51.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 52 | $12,480 | $5,236 | 42.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $9,000 | $2,126 | 23.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 50 | 50 | $43,750 | $2,113 | 4.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $8,200 | $1,930 | 23.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 26 | 31 | $2,635 | $1,183 | 44.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $1,800 | $779.01 | 43.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 12 | 15 | $3,300 | $747.30 | 22.6% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 15 | 15 | $3,150 | $722.15 | 22.9% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 13 | 14 | $3,646 | $658.26 | 18.1% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 15 | 6,000 | $330,000 | $104,024 | 31.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 132 | 133 | $136,325 | $25,249 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 178 | $48,060 | $15,361 | 32.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 105 | 108 | $69,660 | $8,248 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 123 | $22,755 | $7,547 | 33.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 66 | $7,920 | $3,590 | 45.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 34 | $8,160 | $3,563 | 43.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 55 | 55 | $48,125 | $2,455 | 5.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $6,560 | $1,735 | 26.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 15 | 20 | $3,000 | $1,033 | 34.4% |
About Dr. Nina Bandyopadhyay, D.O
Dr. Nina Bandyopadhyay, D.O is a Internal Medicine healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1720309024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nina Bandyopadhyay, D.O has received a total of $3,473 in payments from pharmaceutical and medical device companies, with $940.66 received in 2024. These payments were reported across 189 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,465).
As a Medicare-enrolled provider, Bandyopadhyay has provided services to 2,547 Medicare beneficiaries, totaling 13,158 services with total Medicare billing of $453,915. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Wyomissing, PA
- Active Since 06/21/2010
- Last Updated 04/27/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720309024
Products in Payments
- RINVOQ (Biological) $263.27
- STELARA (Biological) $255.03
- HUMIRA (Biological) $252.30
- ZEPOSIA (Drug) $250.26
- XIFAXAN (Drug) $197.91
- MAVYRET (Drug) $186.85
- LINZESS (Drug) $154.26
- Humira (Biological) $138.20
- Smart Pill (Device) $127.63
- XELJANZ (Drug) $105.20
- VOQUEZNA (Drug) $99.87
- TERLIVAZ (Drug) $99.20
- SKYRIZI (Biological) $71.06
- DUPIXENT (Biological) $69.80
- VIBERZI (Drug) $67.61
- IQIRVO (Drug) $64.01
- CREON (Drug) $62.21
- Entyvio (Biological) $61.80
- Dexilant (Drug) $60.89
- Mavyret (Drug) $59.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wyomissing
Philip Elbaum
Internal Medicine — Payments: $11,913
Internal Medicine $11,913
Dr. David Zisa, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $5,530
Internal Medicine $5,530
J Aynardi, M.d, M.D
Internal Medicine — Payments: $5,018
Internal Medicine $5,018
Evan Butlin, M.d, M.D
Internal Medicine — Payments: $4,218
Internal Medicine $4,218
Brigid Ellis, D.o, D.O
Internal Medicine — Payments: $3,592
Internal Medicine $3,592
Michael Riverso, D.o, D.O
Internal Medicine — Payments: $3,445
Internal Medicine $3,445